Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Procyanidin C1 (PCC1) and NSPCC1

Current understanding

Procyanidin C1 (PCC1) is a grape-seed-derived proanthocyanidin trimer characterized as a natural senolytic in prior mouse work. NSPCC1 is a bioavailability-enhanced oral formulation reported to extend lifespan, rejuvenate hematopoietic stem/progenitor cells, and reduce multi-organ inflammatory aging phenotypes in two mouse aging models [animal-model]. No human outcome data yet; positioning rests on preclinical senolytic mechanism plus animal lifespan/healthspan readouts.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
Hematopoietic Rejuvenation via Natural Senolytic NSPCC1 Delays Inflammatory Aging.
12-jun-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18